Provided by Tiger Trade Technology Pte. Ltd.

CSPC PHARMA

8.805
+0.1051.21%
Volume:55.66M
Turnover:489.54M
Market Cap:101.45B
PE:22.17
High:8.850
Open:8.820
Low:8.685
Close:8.700
52wk High:10.720
52wk Low:6.387
Shares:11.52B
HK Float Shares:11.52B
Volume Ratio:0.45
T/O Rate:0.48%
Dividend:0.34
Dividend Rate:3.83%
EPS(LYR):0.397
ROE:20.90%
ROA:10.70%
PB:2.31
PE(LYR):22.17
PS:2.77

Loading ...

CSPC Pharma Begins Diabetes Drug Trial in China

MT Newswires Live
·
Yesterday

CSPC Pharma Initiates Phase II Clinical Trial of SYH2069 Injection for Type 2 Diabetes at First Chinese Study Center

Stock News
·
Yesterday

CSPC Pharmaceutical Gets Breakthrough Therapy Designation for Lung Cancer Drug

MT Newswires Live
·
Sep 15

Cspc Pharmaceutical Says Sys6010 Granted Breakthrough Therapy Designation by NMPA

Reuters
·
Sep 15

CSPC Pharma's Novel Drug SYS 6010 Receives Breakthrough Therapy Designation in China for Advanced Non-Small Cell Lung Cancer

Stock News
·
Sep 15

CSPC Pharmaceutical - Sys6010 Granted Breakthrough Therapy Designation by Nmpa in China for Nsclc

THOMSON REUTERS
·
Sep 15

CSPC Pharmaceutical Group Stock Sheds 1.9% in Hong Kong, Underperforms Competitors

Dow Jones
·
Sep 15

Record WCLC Data From Chinese Innovators Signals Clear Recovery for CRO/CDMO Sector, Wall Street Takes Notice

Stock News
·
Sep 15

CSPC Pharmaceutical Group Stock Rallies 1.8% in Hong Kong

Dow Jones
·
Sep 14

Big Pharma is Pouring Billions into China's Biotechs

Dow Jones
·
Sep 14

HK Stock Market Update | Innovative Drug Stocks Face Continued Pullback Amid Shifting Overseas Rate Expectations and Post-2026 Negotiation Uncertainty

Stock News
·
Sep 11

CSPC Pharmaceutical Group Stock Slips 3.6% in Hong Kong, Underperforms Competitors

Dow Jones
·
Sep 10

Global Equities Roundup: Market Talk

Dow Jones
·
Sep 10

Hong Kong Market Flash | CSPC Pharma Drops Over 4% as Lp(a) HORIZON Study Setback May Pressure Participants Including the Company

Stock News
·
Sep 10

CSPC Pharma's Clinical Data Presentations Could be Near-Term Share Catalysts

Dow Jones
·
Sep 10

Movement Alert|CSPC PHARMA Falls 3.3% in Regular Trading, Pharma Sector Under Broad Selling Pressure Amid Global Risk-Off

Market Focus
·
Sep 10

CSPC Pharma Gets Clinical Trial Nod in China for Solid Tumors Drug

MT Newswires Live
·
Sep 09

CSPC Pharmaceutical Says Rotigotine Long-Acting Injection Gets Clinical Trial Approval in China

Reuters
·
Sep 09

CSPC PHARMA Wins NMPA Approval to Start Clinical Trial for First Long-Acting Subcutaneous Rotigotine Injection

Bulletin Express
·
Sep 09

CSPC Pharma's Goserelin Extended-Release Injection Gets Clinical Trial Green Light in China

Stock News
·
Sep 09